Latest News - Patents

Thursday, October 05, 2017 | Glaucoma, Patents

New US Patent Allowance Granted to AXIM Biotechnologies for Cannabinoid Ophthalmic Solutions for Glaucoma and Conjunctivitis

AXIM Biotechnologies was granted a patent that claims the use of an ophthalmic solution comprising cannabinoids for the treatment of glaucoma and symptomatic relief of conjunctival inflammation. The U…

Read the full story

Wednesday, October 04, 2017 | Patents, Allergan

U.S. House Committee Launches Probe of Allergan Patent Deal

A U.S. House of Representatives committee launched a probe into drugmaker Allergan's deal to transfer some of its patents to a Native American tribe to shield them from review, according to a repo…

Read the full story

Monday, October 02, 2017 | Patents, Imprimis Pharmaceuticals

Imprimis Pharmaceuticals Secures First Key Composition Patent for Dropless Therapy Formulations

Imprimis Pharmaceuticals announced it has secured its first patent covering the company's Dropless Therapy formulations from the Australian Patent office, a division of IP Australia. Patent 201429…

Read the full story

Monday, September 18, 2017 | Corporate Lawsuits, Patents, Allergan

Allergan's Restasis Patent Transfer to Face Precedent-Setting Legal Battle

Allergan caused a lot of hand-wringing in the biotech community and excitement among patent lawyers, when the drugmaker announced it would transfer patents for Restasis, Allergan's longstandi…

Read the full story

Thursday, August 10, 2017 | Corporate Lawsuits, Patents, PhysIOL sa

PhysIOL: Company Successful in Patent Infringement Action Protecting FINEVISION IOLs

PhysIOL has claimed that the Dusseldorf District Court in Germany has confirmed that VSY Biotechnology infringes the European Patent EP 2 503 962 of PhysIOL S.A. In its judgment on June 29, 2017, the …

Read the full story

Wednesday, July 12, 2017 | Patents, Alphaeon

Strathspey Crown Announces Issuance of US Patent of the First Implantable IOL with a Video Camera and Wireless Transmission Capability

Strathspey Crown announced that the United States Patent and Trademark Office has issued a U.S. Patent (No. 9,662,199) covering an implantable IOL with an optic (including accommodating, multifoc…

Read the full story

Thursday, July 06, 2017 | Patents, Opthea

Opthea Receives Notice of Allowance for Key Patent Covering OPT-302 Eye Disease Drug in the United States

Opthea announced that it has received a Notice of Allowance from the United States Patent and Trade Mark Office for the company's Patent Application No. 14/768,701 for its OPT-302 soluble VEGFR-3 …

Read the full story

Wednesday, January 11, 2017 | Patents

LKC Technologies' Portable RETeval Electrodiagnostic Device and Sensor Strips Earn Two United States Patents

The RETeval device, LKC Technologies' full function flash ERG/VEP system, was granted a patent (USPTO # 9,492,098 B2) on November 15, 2016 for its exclusive stimulus generation, and another patent…

Read the full story

Tuesday, November 15, 2016 | Patents

Guardion Health Sciences Receives Patent for its Diagnostic Device, the MapcatSF

Guardion Health Sciences has announced that the patent for its MapcatSF diagnostic device has been issued by the United States Patent and Trademark Office. The MapcatSF is GHS's premier diagnosti…

Read the full story

Wednesday, October 26, 2016 | Patents

Mati Therapeutics Expands Intellectual Property Portfolio

Mati Therapeutics announced that it has been granted US Patent No. 9,445,944 titled “Lacrimal Implants and Related Methods." The patent, which expires in 2028, claims a method of providing …

Read the full story

Friday, September 23, 2016 | Patents

Lenstec Receives US Patent for Aspherical Multifocal Intraocular Lens

Lenstec announced it has been granted a US patent for its aspherical multifocal IOL (patent number 9,433,496), according to a company news release. The Lenstec SBL 3 IOL (Segmented Bifocal Lens) is…

Read the full story

Friday, September 02, 2016 | Patents, RetroSense Therapeutics

RetroSense Therapeutics Granted Patent on Proprietary Method for Restoring Vision Using Optogenetics

RetroSense Therapeutics announced that the United States Patent and Trademark Office (USPTO) has granted US patent Application No. 11/036,629, entitled “Method for Augmenting Vision in Persons S…

Read the full story

Friday, July 29, 2016 | Patents

Quark Pharmaceuticals Awarded Key Patent for QPI-1007 Ocular Neuroprotectant

Quark Pharmaceuticals announced that the United States Patent and Trademark Office (USPTO) has granted a key patent covering the treatment of patients suffering from non-arteritic anterior ischemic op…

Read the full story

Friday, July 22, 2016 | Patents, Inotek Pharmaceuticals

Inotek Pharmaceuticals Expands Intellectual Property Portfolio with Combination Patent for IOP Lowering

Inotek Pharmaceuticals announced that the United States Patent and Trademark Office issued a composition of matter patent for the combination of the company’s lead product candidate, trabod…

Read the full story

Monday, June 20, 2016 | Cornea, Patents

Eurobio Announces New European and American Corneal Graft Patents

Eurobio announced the attainment of European and American patents for its i-Glide device for the handling and storage of corneal lamellar grafts. The patents are co-owned with the Venice Eye-Bank (FBO…

Read the full story
Load More